Preliminary studies show conolidine may possibly inhibit certain ion channels, decreasing neuronal excitability and limiting ache indicators. This mechanism is particularly appropriate in neuropathic soreness, in which irregular signaling causes persistent pain. Additionally, conolidine appears to affect G protein-coupled receptor (GPCR) pathways i